Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G M Heijerman

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 31, 2015
Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional NebulizationA J van Velzen, A C Bos, D J Touw, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 27, 2002
Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principleA H de Boer, P P H Le Brun, H G van der Woude, et al.
Respiratory Medicine Case Reports|September 22, 2025
Scedosporium infection as a late complication after start of elexacaftor/tezacaftor/ivacaftor: two case reportsP van Mourik, E C van der Hout, H D Luijk, et al.
Pediatric Pulmonology|May 27, 2010
Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort studyM G Slieker, J M W van den Berg, J Kouwenberg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 23, 2006
Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot studyE M Westerman, A H De Boer, P P H Le Brun, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 29, 2007
Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The NetherlandsR W Brimicombe, L Dijkshoorn, T J K van der Reijden, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 16, 2018
Authors' response: Letter to the Editor 'Anaemia and iron deficiency in relation to fatigue in cystic fibrosis'M M Nap-van der Vlist, M Burghard, H J Hulzebos, et al.
Respiratory Medicine|August 27, 2020
Effectiveness of pulmonary rehabilitation at high-altitude compared to sea-level in adults with severe refractory asthmaS B de Nijs, E J M Krop, L Portengen, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 27, 2002
Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patientsP P H Le Brun, A H de Boer, G P M Mannes, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 3, 2010
Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patientsA M M de Vrankrijker, R W Brimicombe, T F W Wolfs, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 31, 2015
Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional NebulizationA J van Velzen, A C Bos, D J Touw, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 27, 2002
Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principleA H de Boer, P P H Le Brun, H G van der Woude, et al.
Respiratory Medicine Case Reports|September 22, 2025
Scedosporium infection as a late complication after start of elexacaftor/tezacaftor/ivacaftor: two case reportsP van Mourik, E C van der Hout, H D Luijk, et al.
Pediatric Pulmonology|May 27, 2010
Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort studyM G Slieker, J M W van den Berg, J Kouwenberg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 23, 2006
Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot studyE M Westerman, A H De Boer, P P H Le Brun, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 29, 2007
Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The NetherlandsR W Brimicombe, L Dijkshoorn, T J K van der Reijden, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 16, 2018
Authors' response: Letter to the Editor 'Anaemia and iron deficiency in relation to fatigue in cystic fibrosis'M M Nap-van der Vlist, M Burghard, H J Hulzebos, et al.
Respiratory Medicine|August 27, 2020
Effectiveness of pulmonary rehabilitation at high-altitude compared to sea-level in adults with severe refractory asthmaS B de Nijs, E J M Krop, L Portengen, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 27, 2002
Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patientsP P H Le Brun, A H de Boer, G P M Mannes, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 3, 2010
Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patientsA M M de Vrankrijker, R W Brimicombe, T F W Wolfs, et al.
Pageof 4